Result Summary for 759346/009
|Clinical Study ID:||759346/009|
|Official Title:||Study to evaluate immunogenicity, reactogenicity and safety of investigational vaccination regimen as compared to GSK Bio’s Hiberix vaccine, extemporaneously mixed with GSK Bio’s Tritanrix-HepB, when administered intramuscularly in infants at 6, 10 and 14 weeks of age|
|Study Indications or Diseases:||
|Generic Name:||Haemophilus influenzae Type b Vaccine|
|Approved Drug Label:||http://www.gsk.com/products.html|
|Results Summary:|| Click
here to download result summary.
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.